623 related articles for article (PubMed ID: 32987946)
1. A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides.
Browne K; Chakraborty S; Chen R; Willcox MD; Black DS; Walsh WR; Kumar N
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987946
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptides (AMPs): a patent review (2015-2020).
Annunziato G; Costantino G
Expert Opin Ther Pat; 2020 Dec; 30(12):931-947. PubMed ID: 33187458
[No Abstract] [Full Text] [Related]
3. Rediscovery of antimicrobial peptides as therapeutic agents.
Ryu M; Park J; Yeom JH; Joo M; Lee K
J Microbiol; 2021 Feb; 59(2):113-123. PubMed ID: 33527313
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides: mechanism of action, activity and clinical potential.
Zhang QY; Yan ZB; Meng YM; Hong XY; Shao G; Ma JJ; Cheng XR; Liu J; Kang J; Fu CY
Mil Med Res; 2021 Sep; 8(1):48. PubMed ID: 34496967
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review.
Mukhopadhyay S; Bharath Prasad AS; Mehta CH; Nayak UY
World J Microbiol Biotechnol; 2020 Aug; 36(9):131. PubMed ID: 32737599
[TBL] [Abstract][Full Text] [Related]
6. Computational resources and tools for antimicrobial peptides.
Liu S; Fan L; Sun J; Lao X; Zheng H
J Pept Sci; 2017 Jan; 23(1):4-12. PubMed ID: 27966278
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptides as therapeutic agents: opportunities and challenges.
Mahlapuu M; Björn C; Ekblom J
Crit Rev Biotechnol; 2020 Nov; 40(7):978-992. PubMed ID: 32781848
[TBL] [Abstract][Full Text] [Related]
8. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance.
Lima PG; Oliveira JTA; Amaral JL; Freitas CDT; Souza PFN
Life Sci; 2021 Aug; 278():119647. PubMed ID: 34043990
[TBL] [Abstract][Full Text] [Related]
9. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
[TBL] [Abstract][Full Text] [Related]
10. Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity.
Liang Y; Zhang X; Yuan Y; Bao Y; Xiong M
Biomater Sci; 2020 Dec; 8(24):6858-6866. PubMed ID: 32815940
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptides: their physicochemical properties and therapeutic application.
Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.
Gan BH; Gaynord J; Rowe SM; Deingruber T; Spring DR
Chem Soc Rev; 2021 Jul; 50(13):7820-7880. PubMed ID: 34042120
[TBL] [Abstract][Full Text] [Related]
13. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
Li J; Fernández-Millán P; Boix E
Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
[TBL] [Abstract][Full Text] [Related]
14. Chemically modified and conjugated antimicrobial peptides against superbugs.
Li W; Separovic F; O'Brien-Simpson NM; Wade JD
Chem Soc Rev; 2021 Apr; 50(8):4932-4973. PubMed ID: 33710195
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections.
Buccini DF; Cardoso MH; Franco OL
Front Cell Infect Microbiol; 2020; 10():612931. PubMed ID: 33614528
[TBL] [Abstract][Full Text] [Related]
16. Identification and design of antimicrobial peptides for therapeutic applications.
Ahmad A; Ahmad E; Rabbani G; Haque S; Arshad M; Khan RH
Curr Protein Pept Sci; 2012 May; 13(3):211-23. PubMed ID: 22612781
[TBL] [Abstract][Full Text] [Related]
17. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.
Starr CG; Ghimire J; Guha S; Hoffmann JP; Wang Y; Sun L; Landreneau BN; Kolansky ZD; Kilanowski-Doroh IM; Sammarco MC; Morici LA; Wimley WC
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8437-8448. PubMed ID: 32241895
[TBL] [Abstract][Full Text] [Related]
18. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
Mirski T; Lidia M; Nakonieczna A; Gryko R
Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
[TBL] [Abstract][Full Text] [Related]
20. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
